These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12187145)

  • 1. Unintentional victims: development of a protocol for the care of children exposed to chemicals at methamphetamine laboratories.
    Mecham N; Melini J
    Pediatr Emerg Care; 2002 Aug; 18(4):327-32. PubMed ID: 12187145
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence of methamphetamine exposure in children removed from clandestine methamphetamine laboratories.
    Grant P; Bell K; Stewart D; Paulson J; Rogers K
    Pediatr Emerg Care; 2010 Jan; 26(1):10-4. PubMed ID: 20042914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposures associated with clandestine methamphetamine drug laboratories in Australia.
    Wright J; Edwards J; Walker S
    Rev Environ Health; 2016 Sep; 31(3):329-52. PubMed ID: 27428841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of children removed from a clandestine methamphetamine laboratory.
    Grant P
    J Emerg Nurs; 2007 Feb; 33(1):31-41. PubMed ID: 17258050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Health Effects Associated with Living in a Former Methamphetamine Drug Laboratory - Victoria, Australia, 2015.
    Wright J; Kenneally ME; Edwards JW; Walker GS
    MMWR Morb Mortal Wkly Rep; 2017 Jan; 65(52):1470-1473. PubMed ID: 28056000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine and the changing face of child welfare: practice principles for child welfare workers.
    Connell-Carrick K
    Child Welfare; 2007; 86(3):125-44. PubMed ID: 17722684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clandestine drug laboratories in Australia and the potential for harm.
    Caldicott DG; Pigou PE; Beattie R; Edwards JW
    Aust N Z J Public Health; 2005 Apr; 29(2):155-62. PubMed ID: 15915620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of intravenous lipid emulsion therapy in acute methamphetamine toxicity.
    Tse J; Ferguson K; Whitlow KS; Erickson K
    Am J Emerg Med; 2016 Aug; 34(8):1732.e3-4. PubMed ID: 26786517
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of toxic gases: methamphetamine inhalation.
    Wells SM; Noonan C; Wells KM; Holian A; Wibbenmeyer LA
    J Burn Care Res; 2009; 30(1):152-4. PubMed ID: 19060736
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute public health consequences of methamphetamine laboratories--16 states, January 2000-June 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Apr; 54(14):356-9. PubMed ID: 15829865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Children and clandestine drug laboratories: the unseen victims.
    Hawkrigg SL; Winterton PM
    Med J Aust; 2013 Dec; 199(11):739-41. PubMed ID: 24329626
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemical hazards related to clandestine drug laboratories.
    Hughart JL
    Arh Hig Rada Toksikol; 2000 Sep; 51(3):305-10. PubMed ID: 11148935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary manifestations of inhaled street drugs.
    Cruz R; Davis M; O'Neil H; Tamarin F; Brandstetter RD; Karetzky M
    Heart Lung; 1998; 27(5):297-305; quiz 306-7. PubMed ID: 9777375
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocardial injury in a Shabu user: late gadolinium multiphocal enhancement.
    Pujol-López M; Ortega-Paz L; Perea RJ; Bosch X
    Med Clin (Barc); 2016 Dec; 147(12):570. PubMed ID: 28266308
    [No Abstract]   [Full Text] [Related]  

  • 15. [Methamphetamine dependence: Consequences and complications].
    Karila L; Petit A; Cottencin O; Reynaud M
    Presse Med; 2010 Dec; 39(12):1246-53. PubMed ID: 20971608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New risks for pulmonary hypertension: need for a large epidemiologic study.
    Willers ED; Newman JH
    Chest; 2006 Dec; 130(6):1633-5. PubMed ID: 17166972
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of surgical treatment in methamphetamine body-stuffers.
    Bahrami-Motlagh H; Hassanian-Moghaddam H; Behnam B; Arab-Ahmadi M
    J Forensic Leg Med; 2015 May; 32():70-2. PubMed ID: 25882154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Benzyl-N-methylphenethylamine (BNMPA), an impurity of illicit methamphetamine synthesis: pharmacological evaluation and interaction with methamphetamine.
    Moore KA; Lichtman AH; Poklis A; Borzelleca JF
    Drug Alcohol Depend; 1995 Aug; 39(2):83-9. PubMed ID: 8529536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel drugs--novel branding.
    Wood DM; Davies S; Calapis A; Ramsey J; Dargan PI
    QJM; 2012 Nov; 105(11):1125-6. PubMed ID: 21997441
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone).
    Dargan PI; Sedefov R; Gallegos A; Wood DM
    Drug Test Anal; 2011; 3(7-8):454-63. PubMed ID: 21755604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.